Hence, the role of CD44 in cancer drug resistance in CD44 knockdown MDA-MB-231 and ZR75 cells, along with CD44-overexpressed MCF7 and ZR75 cells, was evaluated by using chemotherapy drugs, including fluorouracil (5-FU), paclitaxel, and doxorubicin. This evidence concerns the gene CD44 and cancer.